X4 Pharmaceuticals Inc
F:48Q
X4 Pharmaceuticals Inc
F:48Q
Price:
4.902
EUR
Market Closed
Market Cap:
€823.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
X4 Pharmaceuticals Inc
F:48Q
|
US |
|
E
|
Evoke Pharma Inc
F:EV0
|
US |
|
V
|
VAT Group AG
LSE:0RFL
|
CH |
|
Ipsos SA
F:IPZ
|
FR |
|
R
|
Renishaw PLC
F:REW
|
UK |
|
Fundamenta Real Estate AG
SIX:FREN
|
CH |
|
Marex Group PLC
F:8UU
|
UK |
Wall St Price Targets
48Q Price Targets Summary
X4 Pharmaceuticals Inc
X4 Pharmaceuticals Inc
Wall Street analysts forecast 48Q stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 48Q is 14.193 EUR with a low forecast of 12.046 EUR and a high forecast of 16.28 EUR.
Lowest Forecast
Price Target
12.046
EUR
146% Upside
Average Forecast
Price Target
14.193
EUR
190% Upside
Highest Forecast
Price Target
16.28
EUR
232% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 48Q's stock price target?
Price Target
14.193
EUR
14.193
EUR
According to Wall Street analysts, the average 1-year price target for 48Q is 14.193 EUR with a low forecast of 12.046 EUR and a high forecast of 16.28 EUR.
What is the Revenue forecast for X4 Pharmaceuticals Inc?
Projected CAGR
83%
83%
The compound annual growth rate for Revenue over the next 5 years is 83%.
